Dosage & Administration

For subcutaneous infusion only.

Administer at regular intervals from daily up to every two weeks (biweekly).

Individualize dose based on the patient's pharmacokinetic and clinical response.

Monitor serum IgG trough levels regularly to guide subsequent dose adjustments and dosing intervals as needed.

Switching from Immune Globulin Intravenous (Human) treatment (IGIV) or adult patients switching from HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]:

Initial Weekly dose =Previous IGIVor HYQVIA dose (in grams) × 1.30
No. of weeks between IGIVor HYQVIA doses.

Get Your Patient on Cuvitru

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Cuvitru Prescribing Information

Cuvitru Prior Authorization Resources

Most recent Cuvitru prior authorization forms

Most recent state uniform prior authorization forms

Cuvitru PubMed™ News